Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Naomichi Matsumoto, MD"'
Autor:
Kazuo Kodama, MD, Hiromi Aoyama, MD, PhD, Yoshimi Murakami, MD, Jun-ichi Takanashi, MD, PhD, Eriko Koshimizu, PhD, Satoko Miyatake, MD, PhD, Kazuhiro Iwama, MD, PhD, Takeshi Mizuguchi, MD, PhD, Naomichi Matsumoto, MD, PhD, Taku Omata, MD, PhD
Publikováno v:
Radiology Case Reports, Vol 18, Iss 3, Pp 1217-1220 (2023)
Leukoencephalopathy with calcifications and cysts is a rare autosomal recessive genetic disorder neuroradiologically characterized by intracranial calcification, cerebral white matter disease, and multiple cysts. Although SNORD118 genes have recently
Externí odkaz:
https://doaj.org/article/b22a1a9a07024e1ead5eaf1d2c102d44
Autor:
Chiharu Mitsutake, MD, Soichi Muraoka, MD, Hideo Takashima, MD, Hideko Nakashima, MD, Tomoo Yasuda, MD, Naomichi Matsumoto, MD, Koichiro Kumagai, MD, Keijiro Saku, MD
Publikováno v:
Journal of Arrhythmia, Vol 26, Iss 3, Pp 176-180 (2010)
Introduction: Coronary sinus (CS) and biatrial pacing have been reported to be more effective than right atrial appendage (RAA) pacing for preventing atrial fibrillation (AF). However, the effects of atrial pacing on hemodynamics are still unknown. M
Externí odkaz:
https://doaj.org/article/6cd9f6d63d81481983215c5a4e84bdbd
Efficacy of Additional Amiodarone Therapy in Patients with an Implantable Cardioverter-Defibrillator
Autor:
Naomichi Matsumoto, MD, Koichiro Kumagai, MD, Masahiro Ogawa, MD, Kunihiro Matsuo, MD, Tomoo Yasuda, MD, Hideo Takashima, MD, Chiharu Mitsutake, MD, Soichi Muraoka, MD, Akira Matsunaga, MD, Shin-ichiro Miura, MD, Keijiro Saku, MD
Publikováno v:
Journal of Arrhythmia, Vol 26, Iss 2, Pp 103-110 (2010)
Introduction: We examined whether the additional use of amiodarone (AMD) under implantable cardioverter-defibrillator (ICD) therapy may have beneficial effects in patients at risk for lethal ventricular arrhythmias with structural heart diseases. Met
Externí odkaz:
https://doaj.org/article/079a88ef6fa5433aab0de77fe42a5072
Autor:
Soichi Muraoka, MD, Chiharu Mitsutake, MD, Hideo Takashima, MD, Hideko Nakashima, MD, Tomoo Yasuda, MD, Naomichi Matsumoto, MD, Koichiro Kumagai, MD, Keijiro Saku, MD
Publikováno v:
Journal of Arrhythmia, Vol 23, Iss 3, Pp 229-235 (2007)
Introduction: Radiofrequency catheter ablation (RFCA) that targets pulmonary veins (PV) is an established treatment for paroxysmal atrial fibrillation (PAF). Recent studies have demonstrated that RFCA can eliminate PAF in over 90% of patients. Howeve
Externí odkaz:
https://doaj.org/article/1dce643e9e984fc1803d931d93ef9246